Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TADALAFIL for Pulmonary hypertension: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 2,430 adverse event reports in the FDA FAERS database where TADALAFIL was used for Pulmonary hypertension.

Most Reported Side Effects for TADALAFIL

Side Effect Reports % Deaths Hosp.
Headache 3,196 10.4% 94 781
Drug ineffective 2,943 9.6% 47 199
Dyspnoea 2,881 9.4% 213 1,416
Death 1,917 6.3% 1,884 254
Diarrhoea 1,667 5.4% 121 624
Dizziness 1,374 4.5% 38 415
Nausea 1,368 4.5% 59 494
Asthenia 1,230 4.0% 44 261
Fatigue 1,135 3.7% 51 366
Hypertension 1,044 3.4% 9 129
Off label use 1,034 3.4% 81 294
Pain in extremity 911 3.0% 29 230
Back pain 898 2.9% 17 153
Cough 898 2.9% 35 298
Malaise 875 2.9% 75 404

Other Indications for TADALAFIL

Product used for unknown indication (9,275) Pulmonary arterial hypertension (7,679) Erectile dysfunction (6,574) Benign prostatic hyperplasia (1,154) Sexual dysfunction (69) Hypertension (64) Prostatomegaly (51) Prostatic disorder (46) Cor pulmonale chronic (42) Systemic scleroderma (41)

Other Drugs Used for Pulmonary hypertension

AMBRISENTAN (18,885) TREPROSTINIL (10,034) MACITENTAN (5,228) RIOCIGUAT (3,837) SILDENAFIL (3,761) SELEXIPAG (2,500) EPOPROSTENOL (2,486) BOSENTAN (2,337) ILOPROST (1,123) LETAIRIS (854)

Related Pages

TADALAFIL Full Profile All Pulmonary hypertension Drugs TADALAFIL Demographics TADALAFIL Timeline